NYSE · SCUA
Sculptor Acquisition Corp I
$10.52+$0.01 (+0.1%)
Sculptor Acquisition Corp I’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
Loading market information…
NASDAQ · BIOS · USD
Stock price, earnings
Quote as of Oct 6, 2023, 07:46 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BioPlus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow BioPlus Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.52+$0.01 (+0.1%)
Sculptor Acquisition Corp I’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
$10.81-$0.01 (-0.09%)
Iconic Sports Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.28% below the high.
$12.60-$0.24 (-1.87%)
DP Cap Acquisition Corp I’s quoted price sits in the lower half of its reported 52-week range, 19.59% below the high.
$6.58-$3.46 (-34.46%)
Concord Acquisition Corp III’s quoted price sits in the lower half of its reported 52-week range, 62.63% below the high.
$10.84+$0.05 (+0.46%)
SilverBox Corp III’s quoted price sits in the lower half of its reported 52-week range, 6.95% below the high.
$11.60$0.00 (0.0%)
OCA Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
TKB Critical Technologies 1’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$9.20-$0.12 (-1.29%)
Swiftmerge Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
